|1.||Aoki, Junken: 7 articles (09/2012 - 04/2004)|
|2.||Schmitz, Gerd: 6 articles (01/2014 - 12/2002)|
|3.||Liebisch, Gerhard: 6 articles (01/2014 - 12/2002)|
|4.||Sok, Dai-Eun: 5 articles (05/2012 - 05/2009)|
|5.||Kim, Mee Ree: 5 articles (05/2012 - 05/2009)|
|6.||Seppänen-Laakso, Tuulikki: 4 articles (11/2013 - 01/2007)|
|7.||Xu, Guowang: 4 articles (08/2013 - 05/2010)|
|8.||Hung, Nguyen Dang: 4 articles (05/2012 - 12/2009)|
|9.||Arai, Hiroyuki: 4 articles (11/2007 - 04/2004)|
|10.||Bendas, Gerd: 3 articles (12/2015 - 01/2011)|
08/01/2011 - "This study aimed to investigate its cytoprotective effects in rat vascular smooth muscle cells (VSMCs) treated with lysophosphatidylcholine (lysoPC), a key lipid component mediating atherogenesis. "
02/01/2005 - "Previous studies have shown that lysophosphatidylcholine (LPC), a bioactive lipid associated with atherosclerosis and autoimmunity, acts through G2A to induce diverse biologic effects. "
05/30/2008 - "Lysophosphatidylcholine (LPC) has been attributed a pro-inflammatory role in atherosclerosis. "
04/14/2008 - "Lysophosphatidylcholine (LPC) and ADMA are implicated in endothelial dysfunction of atherosclerosis. "
03/01/2008 - "Lysophosphatidylcholine (LysoPtdCho) levels are elevated in sera in patients with atherosclerosis and in atherosclerotic tissue. "
|2.||Cardiac Arrhythmias (Arrythmia)
01/01/1988 - "In this study, the lysophosphatidylcholine level and the occurrence of cardiac arrhythmias in the ischemic canine heart were monitored. "
01/01/1988 - "The production of cardiac arrhythmias and the elevation of lysophosphatidylcholine level in the ischemic myocardium have been well-documented in a number of studies. "
01/01/1997 - "Time course of lysophosphatidylcholine release from ischemic human myocardium parallels the time course of early ischemic ventricular arrhythmia."
08/01/1990 - "The ability of exogenous lysophosphatidylcholine to produce electrophysiological derangements and cardiac arrhythmias in the heart has been documented. "
02/01/1989 - "The accumulation of lysophosphatidylcholine in the heart may be one of the biochemical factors for the production of cardiac arrhythmias."
04/01/2005 - "Stearoyl lysophosphatidylcholine (LPC) has recently been proven protective against lethal sepsis by stimulating neutrophils to eliminate invading pathogens through an H2O2-dependent mechanism. "
10/01/2013 - "As a specific mechanism of exercise-induced adaptation, we identified various lysophosphatidylcholines that might function as surrogate for improved outcome in sepsis."
10/01/2013 - "We identified plasma lysophosphatidylcholine 16:0, lysophosphatidylcholine 17:0, and lysophosphatidylcholine 18:0 as significant metabolites discriminating between trained and untrained mice during sepsis. "
08/01/2012 - "Lysophosphatidylcholine (LPC) has been suggested to serve as a useful prognostic marker for sepsis. "
08/01/2012 - "Clinical significance of enzymatic lysophosphatidylcholine (LPC) assay data in patients with sepsis."
|4.||Demyelinating Diseases (Demyelinating Disease)
01/01/2015 - "To determine whether Olig2 overexpression in adult oligodendrocyte progenitor cells promotes oligodendrocyte regeneration for myelin repair, we induced lysophosphatidylcholine demyelination in the corpus callosum of TetOlig2:Sox10(rtTA/+) and control mice. "
01/01/2014 - "Local demyelination was induced in the corpus callosum of adult female rats via direct injection of lysophosphatidylcholine (LPC) followed by engraftment of BMSC-generated OPCs. "
04/01/2013 - "The standard lysophosphatidylcholine (LPC) injection model was used to induce focal demyelination in the corpus callosum of mice. "
01/01/2013 - "Lysophosphatidylcholine (LPC) was injected stereotaxically to produce a cycle of demyelination-remyelination of the fimbria. "
09/01/2012 - "Demyelination was induced using local injection of lysophosphatidylcholine within the corpus callosum of adult female Sprague-Dawley rats. "
07/25/1993 - "Lysophosphatidylcholine (LPC) increases extracellularly during ischemia in vivo in both animals and man as judged by measurements from venous effluents, but more recent studies have shown little or no increase in buffer-perfused, isolated heart preparations. "
09/15/1990 - "The purpose of this study was to determine whether lysophosphatidylcholine (LPC) release from the myocardium could be detected in patients with pacing-induced ischemia. "
12/06/2013 - "Lysophosphatidylcholine (LPC) is a potent pro-arrhythmic derivative of the membrane phosphotidylcholine, which is accumulated in heart tissues during cardiac ischemia. "
12/01/2003 - "Both 4 h ischemia and ischemia followed by 24 h reperfusion caused a significant increase in lysophosphatidylcholine concentration compared with controls. "
06/01/2003 - "Lysophosphatidylcholine (LPC) is an endogenous phospholipid released from the cell membrane during ischemia, and it has potent, local effects on cardiac tissues. "
|1.||Nonesterified Fatty Acids (NEFA)
|4.||Phospholipases A2 (Phospholipase A2)
|5.||1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)
|7.||Cholesterol Esters (Cholesteryl Esters)
|8.||Ethyl Ether (Ether)
|10.||Tretinoin (Retinoic Acid)
|1.||Heterologous Transplantation (Xenotransplantation)